Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Cubicole D3 5,000unit tablets
0906040G0CKAMCN
|
Cubicole D3 | Colecalciferol | Nutrition and Blood | No data available |
|
Cubicole D3 50,000unit capsules
0906040G0CKAJEQ
|
Cubicole D3 | Colecalciferol | Nutrition and Blood | No data available |
|
Cubicole D3 800unit capsules
0906040G0CKARAN
|
Cubicole D3 | Colecalciferol | Nutrition and Blood | No data available |
|
Cubicole Vitamin C 1000mg effervescent tablets
0906031C0CLAACC
|
Cubicole Vitamin C | Ascorbic acid | Nutrition and Blood | No data available |
|
Cubicole Vitamin C+Z effervescent tablets
091000000BBYFBK
|
Proprietary compound preparation BNF 0910000 | Other compound vitamin/mineral formulation preparations | Nutrition and Blood | No data available |
|
Cubitan liquid
0913342A0BBAAAA
|
Cubitan ready to serve disc or non ACBS m/sk higher protein | Ready to serve disc or non ACBS m/sk higher protein (091334) | Nutrition and Blood | No data available |
|
Cufence 100mg capsules
0908010S0BCABAE
|
Cufence | Trientine dihydrochloride | Nutrition and Blood | No data available |
|
Cufence 200mg capsules
0908010S0BCAAAC
|
Cufence | Trientine dihydrochloride | Nutrition and Blood | No data available |
|
Cuprior 150mg tablets
0908010ASBBAAAA
|
Cuprior | Trientine tetrahydrochloride | Nutrition and Blood | No data available |
|
Cyanocobalamin 35micrograms/5ml oral solution
0901020D0AAAGAG
|
Cyanocobalamin | Cyanocobalamin | Nutrition and Blood | No data available |
|
Cymalon Cranberry extract 200mg tablets
091200000BFQTA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Cynara Artichoke 320mg capsules
091200000BERZA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Cystagon 50mg capsules
0908010E0BBAAAA
|
Cystagon | Mercaptamine | Nutrition and Blood | No data available |
|
Cystine 400mg capsules
0908010AIAAACAC
|
Cystine | Cystine | Nutrition and Blood | No data available |
|
Cystine 500mg capsules
0908010AIAAABAB
|
Cystine | Cystine | Nutrition and Blood | No data available |
|
Cystine 500mg oral powder sachets
0913213A0AAADAD
|
Powder single L-amino acid supplement (0913213) | Powder single L-amino acid supplement (0913213) | Nutrition and Blood | No data available |
|
Cystine 50mg capsules
0908010AIAAAAAA
|
Cystine | Cystine | Nutrition and Blood | No data available |
|
Cystine oral powder
0913445A0AAAHAH
|
Pdr disc/non ACBS single L-amino acid supplement (0913445) | Pdr disc/non ACBS single L-amino acid supplement (0913445) | Nutrition and Blood | No data available |
|
Cytacon 35micrograms/5ml syrup
0901020D0BCABAG
|
Cytacon | Cyanocobalamin | Nutrition and Blood | No data available |
|
Cytacon 50microgram tablets
0901020D0BCAAAE
|
Cytacon | Cyanocobalamin | Nutrition and Blood | No data available |
|
Cytoplan Fish Oil High Potency 1000mg capsules
091200000BFUJA0
|
Proprietary compound preparation BNF 0912000 | Other health supplement preparations | Nutrition and Blood | No data available |
|
Cytoplan Selenium 100microgram tablets
090504700BBDXBJ
|
Proprietary compound preparation BNF 0905047 | Other selenium preparations | Nutrition and Blood | No data available |
|
D-Forte 50,000unit capsules
0906040N0CDAAFL
|
D-Forte | Ergocalciferol | Nutrition and Blood | No data available |
|
D-Max 10,000unit capsules
0906040G0DEABDV
|
D-Max | Colecalciferol | Nutrition and Blood | No data available |
|
D-Max 400unit capsules
0906040G0DEADBI
|
D-Max | Colecalciferol | Nutrition and Blood | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.